Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$31.6K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 14 most recent Form 4 transactions.
| Apr 23 | DAWN | Day One Biopharmaceuticals… | DTOISS◆ | 226,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 23 | DAWN | Day One Biopharmaceuticals… | DTOISS◆ | 171,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 23 | DAWN | Day One Biopharmaceuticals… | DTOISS◆ | 346,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 23 | DAWN | Day One Biopharmaceuticals… | DTOISS | 4,397 | — | — | -100.0% | Open the original filing on SEC.gov |
| Feb 17 | DAWN | Day One Biopharmaceuticals… | SSELL | 2,728 | $11.60 | $31.6K | -38.3% | Open the original filing on SEC.gov |
| Feb 15 | DAWN | Day One Biopharmaceuticals… | MEXER◆ | 7,125 | — | — | — | Open the original filing on SEC.gov |
| Feb 15 | DAWN | Day One Biopharmaceuticals… | MEXER | 7,125 | — | — | — | Open the original filing on SEC.gov |
| Jan 30 | DAWN | Day One Biopharmaceuticals… | AGRANT◆ | 114,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 30 | DAWN | Day One Biopharmaceuticals… | AGRANT◆ | 171,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 16, 2025 | DAWN | Day One Biopharmaceuticals… | AGRANT◆ | 226,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 16, 2025 | DAWN | Day One Biopharmaceuticals… | AGRANT◆ | 346,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | KURA | Kura Oncology, Inc. | AGRANT◆ | 28,500 | — | — | — | Open the original filing on SEC.gov |